Site içinde arama yapın

bir ses eklendi Health

2026-02-13 06:47:52 -

The "Neurological" Horizon: How 2026 is Using "Hot" Molecules to Treat Alzheimer's.

In late 2026, the industry is pivoting toward "Neuro-Theranostics." While oncology remains the anchor, a radical new class of "Amyloid-Clearing Radiopharmaceuticals" has entered Phase 2 trials, aiming to use targeted radiation to break down the plaques associated with Alzheimer's disease. This innovation is a primary driver for the market, as it promises to treat the brain with...

0 Yorumlar 0 hisse senetleri 14 Views 0 önizleme